Hygeia Healthcare Holdings Crescita futura

Future criteri di controllo 4/6

Hygeia Healthcare Holdings prevede che gli utili e i ricavi cresceranno rispettivamente di 21.3% e 15% all'anno. Si prevede che l'EPS crescerà di 21.3% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 13.4% in 3 anni.

Informazioni chiave

21.3%

Tasso di crescita degli utili

21.3%

Tasso di crescita dell'EPS

Healthcare crescita degli utili	18.5%
Tasso di crescita dei ricavi	15.0%
Rendimento futuro del capitale proprio	13.4%
Copertura analitica	Good
Ultimo aggiornamento	21 Nov 2024

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

Previsioni di crescita degli utili e dei ricavi

SZSC:6078 - Stime future degli analisti e dati finanziari passati (CNY Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2026	7,411	1,254	1,442	1,714	13
12/31/2025	6,224	992	1,085	1,488	16
12/31/2024	5,296	824	715	1,114	16
6/30/2024	4,699	733	59	783	N/A
3/31/2024	4,388	708	-49	783	N/A
12/31/2023	4,077	683	-158	783	N/A
9/30/2023	3,753	635	-157	764	N/A
6/30/2023	3,429	587	-156	744	N/A
3/31/2023	3,312	532	-39	715	N/A
12/31/2022	3,196	477	78	685	N/A
9/30/2022	3,053	472	-23	620	N/A
6/30/2022	2,910	468	-125	554	N/A
3/31/2022	2,613	455	-184	490	N/A
12/31/2021	2,315	441	-243	426	N/A
9/30/2021	2,008	403	-165	379	N/A
6/30/2021	1,701	365	-88	332	N/A
3/31/2021	1,551	268	-58	314	N/A
12/31/2020	1,402	170	-29	296	N/A
9/30/2020	1,302	100	-12	271	N/A
6/30/2020	1,203	29	4	246	N/A
3/31/2020	1,145	35	37	237	N/A
12/31/2019	1,086	40	69	229	N/A
12/31/2018	766	3	-131	160	N/A
12/31/2017	596	-46	N/A	67	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di 6078 ( 21.3% all'anno) è superiore al tasso di risparmio ( 2.3% ).

Guadagni vs Mercato: Si prevede che gli utili di 6078 ( 21.3% all'anno) cresceranno più rapidamente del mercato Hong Kong ( 11.6% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di 6078 cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di 6078 ( 15% all'anno) crescerà più rapidamente del mercato Hong Kong ( 7.8% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di 6078 ( 15% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di 6078 sarà basso tra 3 anni ( 13.4 %).

Hygeia Healthcare Holdings Crescita futura

Future criteri di controllo 4/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Recent updates

Investor sentiment improves as stock rises 34%

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 21%

First half 2024 earnings released: EPS: CN¥0.61 (vs CN¥0.53 in 1H 2023)

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2024 Results on Aug 29, 2024

Full year 2023 earnings released: EPS: CN¥1.08 (vs CN¥0.77 in FY 2022)

Chairman & Co-CEO recently bought HK$13m worth of stock

Investor sentiment improves as stock rises 21%

Hygeia Healthcare Holdings Co., Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: EPS: CN¥1.08 (vs CN¥0.77 in FY 2022)

Hygeia Healthcare Holdings Co., Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

Chairman & Co-CEO recently bought HK$4.1m worth of stock

Chairman & Co-CEO recently bought HK$20m worth of stock

Investor sentiment deteriorates as stock falls 24%

Chairman & Co-CEO recently bought HK$9.0m worth of stock

First half 2023 earnings released: EPS: CN¥0.53 (vs CN¥0.36 in 1H 2022)

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2023 Results on Aug 29, 2023

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) entered into the acquisition agreement to acquire Datang International (Hong Kong) Limited for CNY 1.2 billion.

Now 22% undervalued after recent price drop

Upcoming dividend of CN¥0.15 per share at 0.4% yield

Full year 2022 earnings released: EPS: CN¥0.77 (vs CN¥0.71 in FY 2021)

Hygeia Healthcare Holdings Co., Limited has completed a Follow-on Equity Offering in the amount of HKD 791.8 million.

Hygeia Healthcare Holdings Co., Limited Announces Chief Financial Officer Changes

Now 22% undervalued after recent price drop

Less than half of directors are independent

Now 22% undervalued after recent price drop

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) acquired 30% of KAIYUAN JIEHUA HOSPITAL CO., LTD for CNY 15.3 million.

First half 2022 earnings released: EPS: CN¥0.36 (vs CN¥0.32 in 1H 2021)

Hygeia Healthcare Holdings Co., Limited Omits Dividend for the Six Months Ended June 30, 2022

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2022 Results on Aug 31, 2022

Investor sentiment improved over the past week

Hygeia Healthcare Holdings Co., Limited Announces Management Changes

Full year 2021 earnings released: EPS: CN¥0.71 (vs CN¥0.38 in FY 2020)

Less than half of directors are independent

Full year 2021 earnings released: EPS: CN¥0.71 (vs CN¥0.38 in FY 2020)

Hygeia Healthcare Holdings Co., Limited Resolves Not to Declare Final Dividend for the Year Ended December 31, 2021

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Chairman & Co-CEO recently bought HK$15m worth of stock

Joint Company Secretary recently bought HK$11m worth of stock

Investor sentiment deteriorated over the past week

Chairman & Co-CEO recently bought HK$4.4m worth of stock

First half 2021 earnings released: EPS CN¥0.32 (vs CN¥0.008 in 1H 2020)

First half 2021 earnings released: EPS CN¥0.32 (vs CN¥0.008 in 1H 2020)

Board Member recently sold HK$6.2m worth of stock

Director of Research & Development recently sold HK$2.7m worth of stock

Full year 2020 earnings released: EPS CN¥0.38 (vs CN¥0.14 in FY 2019)

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) entered into a share purchase agreement to acquire 98% stake in Suzhou Yongding Hospital from Ascendent Capital Partners I, L.P. managed by Ascendent Capital Partners (Asia) Limited for CNY 1.7 billion.

Full year 2020 earnings released: EPS CN¥0.38 (vs CN¥0.14 in FY 2019)

Hygeia Healthcare Holdings Co., Limited to Report Fiscal Year 2020 Results on Mar 29, 2021

New 90-day low: HK$45.50

Hygeia Healthcare Holdings Co., Limited Announces Change of Joint Company Secretary

New 90-day high: HK$61.15

Hygeia Healthcare Holdings Co., Limited Announces Management Changes

Insider recently bought HK$8.2m worth of stock

First half earnings released

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita